tiprankstipranks
Trending News
More News >
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460

Sihuan Pharmaceutical Holdings Group (0460) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of $9.61B. The enterprise value is ―.
Market Cap$9.61B
Enterprise Value

Share Statistics

Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,329,999,000
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -2.05%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-2.05%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee712.83K
Profits Per Employee-160.59K
Employee Count2,667
Asset Turnover0.18
Inventory Turnover1.58

Valuation Ratios

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is -26.51. Sihuan Pharmaceutical Holdings Group’s PEG ratio is 0.06.
PE Ratio-26.51
PS Ratio0.00
PB Ratio1.38
Price to Fair Value1.31
Price to FCF-506.73
Price to Operating Cash Flow165.18
PEG Ratio0.06

Income Statement

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of 1.90B and earned -216.66M in profits. Earnings per share was -0.02.
Revenue1.90B
Gross Profit1.24B
Operating Income-138.13M
Pretax Income-428.29M
Net Income-216.66M
EBITDA-208.66M
Earnings Per Share (EPS)-0.02

Cash Flow

In the last 12 months, operating cash flow was 36.46M and capital expenditures -48.34M, giving a free cash flow of -11.88M billion.
Operating Cash Flow36.46M
Free Cash Flow-11.88M
Free Cash Flow per Share>-0.01

Dividends & Yields

Sihuan Pharmaceutical Holdings Group pays an annual dividend of HK$0.02, resulting in a dividend yield of 2.04%
Dividend Per ShareHK$0.02
Dividend Yield2.04%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.91
52-Week Price Change101.96%
50-Day Moving Average0.73
200-Day Moving Average0.65
Relative Strength Index (RSI)71.36
Average Volume (3m)116.89M

Important Dates

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateSep 27, 2024

Financial Position

Sihuan Pharmaceutical Holdings Group as a current ratio of 1.73, with Debt / Equity ratio of 21.56%
Current Ratio1.73
Quick Ratio1.60
Debt to Market Cap0.15
Net Debt to EBITDA12.36
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid 43.26M in taxes.
Income Tax43.26M
Effective Tax Rate-0.10

Enterprise Valuation

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is -15.16, with an EV/FCF ratio of 0.00.
EV to Sales1.66
EV to EBITDA-15.16
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Sihuan Pharmaceutical Holdings Group has $3.63B in cash and marketable securities with ¥942.76M in debt, giving a net cash position of -$2.69B billion.
Cash & Marketable Securities$3.63B
Total Debt¥942.76M
Net Cash-$2.69B
Net Cash Per Share-$0.29
Tangible Book Value Per Share$0.47

Margins

Gross margin is 65.32%, with operating margin of -7.27%, and net profit margin of -11.40%.
Gross Margin65.32%
Operating Margin-7.27%
Pretax Margin-22.53%
Net Profit Margin-11.40%
EBITDA Margin-10.98%
EBIT Margin-20.48%

Analyst Forecast

The average price target for Sihuan Pharmaceutical Holdings Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-0.11%
EPS Growth Forecast-290.77%

Scores

Smart Score7
AI Score51
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis